Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
Submitted by
admin
on September 18, 2017 - 9:23am
Source:
BioPharma Dive
News Tags:
Samsung Bioepis
EMA
Europe
biosimilars
Herceptin
Roche
breast cancer
Headline:
Samsung Bioepis first to secure EMA backing for Herceptin biosimilar
Do Not Allow Advertisers to Use My Personal information
